| PERIOD ENDING | 6-Aug-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
| 94,433 | 93,600 | 94,838 | | Cost of Revenue | 75,802 | (13,191) | 61,816 | 67,575 | | | Gross Profit | (75,802) | 107,624 | 31,784 | 27,263 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (170) | 7,466 | 6,700 | 3,090 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | (47,051) |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (352) | 24,526 | 25,084 | 24,173 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 138 | 123 | (257) | 397 | | Earnings Before Interest And Taxes | (352) | 24,591 | 25,023 | 23,826 | | Interest Expense | 138 | 15,060 | 14,835 | 16,433 | | Income Before Tax | (490) | 9,531 | 10,188 | 7,393 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| (456) | | | | Net Income From Continuing Ops |
-
| 9,237 | 9,992 | 7,393 | | | Non-recurring Events | | Discontinued Operations |
-
| 1,481 | 1,853 | 340 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,276 | 9,442 | 11,845 | 7,733 | | Preferred Stock And Other Adjustments | (1,276) | (2,511) | (3,922) | (3,216) | | | Net Income Applicable To Common Shares |
-
| $6,931 | $7,923 | $4,517 |
|
0.51% Nasdaq 
Income Statement
